Aesthetics

young woman smiling behind a leaf

At Yukon Eye, we provide a selection of premium aesthetic procedures, including iProX, Lumify, Upneeq, and LATISSE®.

LATISSE®

“LATISSE® is the first prescription product to treat inadequate lashes—it’s believed to prolong the active eyelash growth phase. It’s clinically proven to deliver lashes that are fuller, longer, and darker at 16 weeks.”1

iProX

“The iProX, from MDelite  is a first of its kind aesthetic device featuring intense pulsed light (IPL) technology and advanced capabilities that deliver a best-in-class patient experience coupled with Radio Frequency (RF) technology. From addressing skin discoloration and acne to vascular inflammation, iProX is a diverse system designed to maximize treatment outcomes for a wide range of conditions.
Unlike other IPL devices on the market, this revolutionary light platform delivers synergistic pulses of energy through an ergonomically designed handpiece to establish pathways for deeper penetration, resulting in a safe, effective, and more comfortable treatment experience for patients of all skin types.”2

Upneeq

“Upneeq is the only FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.”3

Lumify

“Try LUMIFY, the amazing eye drop that significantly reduces redness to help your eyes look whiter and brighter, and reveal their natural beauty.
You won’t believe your eyes!”4

Learn more about the aesthetic services offered at Yukon Eye in Fairbanks, AK, by requesting an appointment today!

  1. LATISSE®, https://www.latisse.com/. ↩︎
  2. iProX, https://mdelitelaser.com/iprox-rf-ipl-laser-device/ ↩︎
  3. Upneeq, https://www.upneeq.com/index.html ↩︎
  4. Lumify, https://www.lumifydrops.com/ ↩︎
(907) 888-8174
Book appointment
Patient Portal
Contact Us

Our location

1275 Sadler Way, Suite #103

Fairbanks, Alaska 99701

Fax (855) 729-1235

Phone (907) 888-8174

Directions
WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.